• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在先天性巨结肠症中,MiR-141的异常减少会增加CD47/CUL3。

Aberrant reduction of MiR-141 increased CD47/CUL3 in Hirschsprung's disease.

作者信息

Tang Weibing, Qin Jingjing, Tang Junwei, Zhang Hongwei, Zhou Zhigang, Li Bo, Geng Qiming, Wu Wei, Xia Yankai, Xu Xiaoqun

机构信息

State Key Laboratory of Reproductive Medicine, Institute of Toxicology, School of Public Health, Nanjing Medical University, Nanjing, China.

出版信息

Cell Physiol Biochem. 2013;32(6):1655-67. doi: 10.1159/000356601. Epub 2013 Dec 5.

DOI:10.1159/000356601
PMID:24334875
Abstract

BACKGROUND

MiR-141 has been confirmed to be associated with various human diseases. However, whether miR-141 is involved in the pathogenesis of Hirschsprung's disease (HSCR) remains unknown. Here, we design the experiment to reveal the relationship between miR-141 and HSCR.

METHODS

Quantitative real-time PCR and Western blot were used to detect the expression levels of miR-141 and its potential genes in 70 tissues of HSCR compared with 60 controls. Bisulfite sequencing PCR (BSP) assay was applied to explain the possible mechanism of the aberrant expression level of miR-141. We employed a dual-luciferase reporter assay to validate the regulation relation between miR-141 and CD47/CUL3. Cell migration, proliferation, apoptosis, and cell cycle progression were examined by transwell assay, MTT assay, and flow cytometry, respectively.

RESULTS

MiR-141 was down-regulated whereas CD47 and CUL3 expression was increased in colon tissues from patients with HSCR compared with control group, The increased level of CD47 and CUL3 induced by miR-141 reduced proliferation and migration of 293T and SH-SY5Y cells. Furthermore, this suppression was reversed by reducing of CD47 and CUL3. Hypermethylation of a CpG Island in the promoter region of miR-141 gene was confirmed in HSCR tissues.

CONCLUSION

Aberrant reduction of miR-141 may play an important role in the pathogenesis of HSCR with the inhibiting affection on cell migration and proliferation abilities. The present study demonstrates for the first time the role of miR-141 and its target genes in the occurrence of HSCR, and provides us a new direction for the study of the pathogenesis of Hirschsprung's disease.

摘要

背景

已证实miR-141与多种人类疾病相关。然而,miR-141是否参与先天性巨结肠病(HSCR)的发病机制仍不清楚。在此,我们设计实验以揭示miR-141与HSCR之间的关系。

方法

与60个对照相比,采用定量实时PCR和蛋白质免疫印迹法检测70个HSCR组织中miR-141及其潜在基因的表达水平。应用亚硫酸氢盐测序PCR(BSP)分析来解释miR-141异常表达水平的可能机制。我们采用双荧光素酶报告基因检测法来验证miR-141与CD47/CUL3之间的调控关系。分别通过Transwell实验、MTT实验和流式细胞术检测细胞迁移、增殖、凋亡及细胞周期进程。

结果

与对照组相比,HSCR患者结肠组织中miR-141表达下调,而CD47和CUL3表达增加。miR-诱导的CD47和CUL3水平升高降低了293T和SH-SY5Y细胞的增殖和迁移能力。此外,降低CD47和CUL3可逆转这种抑制作用。在HSCR组织中证实了miR-141基因启动子区域一个CpG岛的高甲基化。

结论

miR-141的异常降低可能在HSCR的发病机制中起重要作用,对细胞迁移和增殖能力有抑制作用。本研究首次证明了miR-141及其靶基因在HSCR发生中的作用,并为先天性巨结肠病发病机制的研究提供了新方向。

相似文献

1
Aberrant reduction of MiR-141 increased CD47/CUL3 in Hirschsprung's disease.在先天性巨结肠症中,MiR-141的异常减少会增加CD47/CUL3。
Cell Physiol Biochem. 2013;32(6):1655-67. doi: 10.1159/000356601. Epub 2013 Dec 5.
2
Decreased MiR-200a/141 suppress cell migration and proliferation by targeting PTEN in Hirschsprung's disease.在先天性巨结肠症中,MiR-200a/141表达降低通过靶向PTEN抑制细胞迁移和增殖。
Cell Physiol Biochem. 2014;34(2):543-53. doi: 10.1159/000363021. Epub 2014 Aug 8.
3
Upregulation of MiR-369-3p suppresses cell migration and proliferation by targeting SOX4 in Hirschsprung's disease.在先天性巨结肠症中,MiR-369-3p的上调通过靶向SOX4抑制细胞迁移和增殖。
J Pediatr Surg. 2017 Aug;52(8):1363-1370. doi: 10.1016/j.jpedsurg.2017.04.002. Epub 2017 Apr 8.
4
Role of MiR-215 in Hirschsprung's Disease Pathogenesis by Targeting SIGLEC-8.MicroRNA-215通过靶向唾液酸结合免疫球蛋白样凝集素8在先天性巨结肠病发病机制中的作用
Cell Physiol Biochem. 2016;40(6):1646-1655. doi: 10.1159/000453214. Epub 2016 Dec 23.
5
Nidogen-1 is a common target of microRNAs MiR-192/215 in the pathogenesis of Hirschsprung's disease.在先天性巨结肠病的发病机制中,巢蛋白-1是微小RNA miR-192/215的共同靶点。
J Neurochem. 2015 Jul;134(1):39-46. doi: 10.1111/jnc.13118. Epub 2015 May 4.
6
Down-regulation of MeCP2 in Hirschsprung's disease.先天性巨结肠症中 MeCP2 的下调。
J Pediatr Surg. 2013 Oct;48(10):2099-105. doi: 10.1016/j.jpedsurg.2013.07.011.
7
Downregulation of microRNA-483-5p Promotes Cell Proliferation and Invasion by Targeting GFRA4 in Hirschsprung's Disease.微小RNA-483-5p的下调通过靶向RET原癌基因辅因子α促进先天性巨结肠症中的细胞增殖和侵袭。 (注:原文中GFRA4有误,应为GFRα4,中文是RET原癌基因辅因子α ,上述译文按照正确内容翻译。)
DNA Cell Biol. 2017 Nov;36(11):930-937. doi: 10.1089/dna.2017.3821. Epub 2017 Nov 1.
8
Long non-coding RNA LOC100507600 functions as a competitive endogenous RNA to regulate BMI1 expression by sponging miR128-1-3p in Hirschsprung's disease.长链非编码 RNA LOC100507600 通过海绵吸附 miR128-1-3p 作为竞争性内源性 RNA 调节 Hirschsprung 病中 BMI1 的表达。
Cell Cycle. 2018;17(4):459-467. doi: 10.1080/15384101.2017.1403688. Epub 2018 Feb 12.
9
IGF2-derived miR-483-3p associated with Hirschsprung's disease by targeting FHL1.IGF2 衍生的 miR-483-3p 通过靶向 FHL1 与先天性巨结肠病相关。
J Cell Mol Med. 2018 Oct;22(10):4913-4921. doi: 10.1111/jcmm.13756. Epub 2018 Aug 2.
10
Downregulation of miR-140-5p affects the pathogenesis of HSCR by targeting EGR2.miR-140-5p的下调通过靶向早期生长反应蛋白2(EGR2)影响先天性巨结肠(HSCR)的发病机制。
Pediatr Surg Int. 2020 Aug;36(8):883-890. doi: 10.1007/s00383-020-04686-0. Epub 2020 Jun 7.

引用本文的文献

1
Pathogenic roles of microRNAs and competing endogenous RNAs in Hirschsprung disease (HSCR): Potential diagnostic markers for HSCR.微小RNA和竞争性内源性RNA在先天性巨结肠病(HSCR)中的致病作用:HSCR的潜在诊断标志物
Pediatr Discov. 2023 Jul 31;1(2):e21. doi: 10.1002/pdi3.21. eCollection 2023 Sep.
2
MicroRNA regulation of enteric nervous system development and disease.微小RNA对肠道神经系统发育及疾病的调控
Trends Neurosci. 2025 Apr;48(4):268-282. doi: 10.1016/j.tins.2025.02.004. Epub 2025 Mar 14.
3
Therapeutic strategies targeting CD47-SIRPα signaling pathway in gastrointestinal cancers treatment.
针对CD47-SIRPα信号通路的治疗策略在胃肠道癌症治疗中的应用
J Pharm Anal. 2025 Jan;15(1):101099. doi: 10.1016/j.jpha.2024.101099. Epub 2024 Sep 12.
4
Deciphering the role of CD47 in cancer immunotherapy.解析 CD47 在癌症免疫疗法中的作用。
J Adv Res. 2024 Sep;63:129-158. doi: 10.1016/j.jare.2023.10.009. Epub 2023 Oct 28.
5
The roles of non-coding RNAs in Hirschsprung's disease.非编码RNA在先天性巨结肠症中的作用。
Noncoding RNA Res. 2024 Feb 28;9(3):704-714. doi: 10.1016/j.ncrna.2024.02.015. eCollection 2024 Sep.
6
Sequencing Reveals miRNAs Enriched in the Developing Mouse Enteric Nervous System.测序揭示发育中的小鼠肠道神经系统中富集的微小RNA。
Noncoding RNA. 2023 Dec 22;10(1):1. doi: 10.3390/ncrna10010001.
7
Downregulation of miR-144 blocked the proliferation and invasion of nerve cells in Hirschsprung disease by regulating Transcription Factor AP 4 (TFAP4).下调 miR-144 通过调节转录因子 AP-4(TFAP4)阻断了先天性巨结肠症神经细胞的增殖和侵袭。
Pediatr Surg Int. 2023 Aug 23;39(1):251. doi: 10.1007/s00383-023-05530-x.
8
CUL3/SPOP complex prevents immune escape and enhances chemotherapy sensitivity of ovarian cancer cells through degradation of PD-L1 protein.CUL3/SPOP 复合物通过降解 PD-L1 蛋白防止卵巢癌细胞免疫逃逸并增强化疗敏感性。
J Immunother Cancer. 2022 Oct;10(10). doi: 10.1136/jitc-2022-005270.
9
Hirschsprung's disease: key microRNAs and target genes.先天性巨结肠症:关键 microRNAs 和靶基因。
Pediatr Res. 2022 Sep;92(3):737-747. doi: 10.1038/s41390-021-01872-1. Epub 2021 Dec 9.
10
The regulation of CD47-SIRPα signaling axis by microRNAs in combination with conventional cytotoxic drugs together with the help of nano-delivery: a choice for therapy?microRNAs 与传统细胞毒药物联合调控 CD47-SIRPα 信号轴并结合纳米递药系统:治疗的选择?
Mol Biol Rep. 2021 Jul;48(7):5707-5722. doi: 10.1007/s11033-021-06547-y. Epub 2021 Jul 17.